Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism

Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies

Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,525

Antidepressant effects of ketamine in depressed patients

Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856

mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926

Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex

Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants

Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750

Synaptic Dysfunction in Depression: Potential Therapeutic Targets

Duman, R. S., & Aghajanian, G. K. (2012) · Science · doi:10.1126/science.1222939 · Cited by 1,651

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., et al. (2016) · Nature · doi:10.1038/nature17998 · Cited by 1,609

Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors

Maeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103

Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure

Li, N., Liu, R.-J., Dwyer, J. M., Banasr, M., Lee, B., Son, H., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.015 · Cited by 1,082

Dendritic structural plasticity and neuropsychiatric disease

Forrest, M. P., Parnell, E., & Penzes, P. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2018.16 · Cited by 464

Dysregulation of adult hippocampal neuroplasticity in major depression: Pathogenesis and therapeutic implications

Tartt, A. N., Mariani, M. B., Hen, R., Mann, J. J., & Boldrini, M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01520-y · Cited by 408

Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis

Bahji, A., Vazquez, G. H., & Zarate, C. A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.071 · Cited by 408

Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics

Aleksandrova, L. R., & Phillips, A. G. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.08.003 · Cited by 276

Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics.

de Vos, C. M. H., Mason, N. L., & Kuypers, K. P. C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.724606 · Cited by 269

Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine

Gregorio, D. D., Aguilar‐Valles, A., Preller, K. H., Heifets, B. D., Hibicke, M., Mitchell, J., & Gobbi, G. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1659-20.2020 · Cited by 278

Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms

Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232

Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers

Matveychuk, D., Thomas, R. K., Swainson, J., Khullar, A., MacKay, M.-A., Baker, G. B., & Dursun, S. M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320916657 · Cited by 209

Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder

Cutler, A. J., Mattingly, G. W., & Maletic, V. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02514-2 · Cited by 156

Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study)

Martinotti, G., Vita, A., Fagiolini, A., Maina, G., Bertolino, A., Dell'Osso, B., Siracusano, A., Clerici, M., Bellomo, A., Sani, G., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.09.043 · Cited by 146

The molecular pathophysiology of depression and the new therapeutics

Tian, H., Hu, Z., Xu, J., & Wang, C. (2022) · MedComm · doi:10.1002/mco2.156 · Cited by 122

Depression: Biological markers and treatment

Erjavec, G. N., Šagud, M., Perković, M. N., Štrac, D. Š., Konjevod, M., Tudor, L., Uzun, S., & Pivac, N. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110139 · Cited by 127

The Nucleus Accumbens: A Common Target in the Comorbidity of Depression and Addiction

Xu, L., Nan, J., & Lan, Y. (2020) · Frontiers in Neural Circuits · doi:10.3389/fncir.2020.00037 · Cited by 123

Evaluation of the Wistar-Kyoto rat model of depression and the role of synaptic plasticity in depression and antidepressant response

Aleksandrova, L. R., Wang, Y. T., & Phillips, A. G. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.07.007 · Cited by 114

Novel drug developmental strategies for treatment‐resistant depression

Borbély, É., Simon, M., Fuchs, E., Wiborg, O., Czéh, B., & Helyes, Z. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15753 · Cited by 116

Perspectives for therapy of treatment‐resistant depression

Papp, M., Cubała, W. J., Święcicki, Ł., Newman‐Tancredi, A., & Willner, P. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15596 · Cited by 96

Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression

Aleksandrova, L. R., Wang, Y. T., & Phillips, A. G. (2020) · Molecular Brain · doi:10.1186/s13041-020-00627-z · Cited by 85

The Psychedelic Future of Post-Traumatic Stress Disorder Treatment

Zaretsky, T. G., Jagodnik, K. M., Barsic, R., Antonio, J. H., Bonanno, P. A., MacLeod, C., Pierce, C., Carney, H., Morrison, M. T., Saylor, C. F., et al. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666231027111147 · Cited by 91

Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors

Lazarevic, V., Yang, Y., Flais, I., & Svenningsson, P. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01246-3 · Cited by 81

Targeting inflammation: a potential approach for the treatment of depression

Bhatt, S., Devadoss, T., Jha, N. K., Baidya, M., Gupta, G., Chellappan, D. K., Singh, S. K., & Dua, K. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01095-1 · Cited by 83

Targeting Inflammatory-Mitochondrial Response in Major Depression: Current Evidence and Further Challenges

Visentin, A. P. V., Colombo, R., Scotton, E., Fracasso, D. S., Rosa, A. R., Branco, C. S., & Salvador, M. M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2972968 · Cited by 77

Inhibition of activated astrocyte ameliorates lipopolysaccharide- induced depressive-like behaviors

Wang, Y., Ni, J., Zhai, L., Gao, C., Xie, L., Zhao, L., & Yin, X. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.08.015 · Cited by 75

Ketamine activates adult-born immature granule neurons to rapidly alleviate depression-like behaviors in mice

Rawat, R., Tunc‐Ozcan, E., McGuire, T. L., Peng, C., & Kessler, J. A. (2022) · Nature Communications · doi:10.1038/s41467-022-30386-5 · Cited by 77

Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis

Bahji, A., Zarate, C. A., & Vázquez, G. H. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2047928 · Cited by 76

Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine

Chen, B. K., Luna, V. M., LaGamma, C. T., Xu, X., Deng, S., Suckow, R. F., Cooper, T. B., Shah, A., Brachman, R. A., Mendez‐David, I., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0714-z · Cited by 68

A Review of Nonanesthetic Uses of Ketamine

Pribish, A. M., Wood, N. J., & Kalava, A. (2020) · Anesthesiology Research and Practice · doi:10.1155/2020/5798285 · Cited by 73

Modulation of amygdala reactivity following rapidly acting interventions for major depression

Loureiro, J. R., Leaver, A. M., Vasavada, M. M., Sahib, A. K., Kubicki, A., Joshi, S. H., Woods, R. P., Wade, B., Congdon, E. L., Espinoza, R. T., et al. (2020) · Human Brain Mapping · doi:10.1002/hbm.24895 · Cited by 64

Antidepressant mechanisms of ketamine: a review of actions with relevance to treatment-resistance and neuroprogression

Lullau, A. P. M., Haga, E. M. W., Ronold, E. H., & Dwyer, G. E. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1223145 · Cited by 63

Research progress on classical traditional chinese medicine formula xiaoyaosan in the treatment of depression

Chen, J., Lei, C., Li, X., Wu, Q., Liu, C., Ma, Q., & Chen, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.925514 · Cited by 63

Ketamine, Esketamine, and Arketamine: Their Mechanisms of Action and Applications in the Treatment of Depression and Alleviation of Depressive Symptoms

Kawczak, P., Feszak, I. J., & Bączek, T. (2024) · Biomedicines · doi:10.3390/biomedicines12102283 · Cited by 66

Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review

Keeler, J. L., Treasure, J. L., Juruena, M. F., Kan, C., & Himmerich, H. (2021) · Nutrients · doi:10.3390/nu13114158 · Cited by 58

Alcohol Exposure Induces Depressive and Anxiety-like Behaviors via Activating Ferroptosis in Mice

Xu, C., Xiong, Q., Tian, X., Liu, W., Sun, B., Ru, Q., & Shu, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213828 · Cited by 56

On the varieties of conscious experiences: Altered Beliefs Under Psychedelics (ALBUS)

Safron, A., Juliani, A., Reggente, N., Klimaj, V., & Johnson, M. W. (2025) · Neuroscience of Consciousness · doi:10.1093/nc/niae038 · Cited by 57

Understanding the Biological Relationship between Migraine and Depression

Viudez‐Martínez, A., Torregrosa, A. B., Navarrete, F., & García‐Gutiérrez, M. S. (2024) · Biomolecules · doi:10.3390/biom14020163 · Cited by 56

Sub-anesthetic and anesthetic ketamine produce different long-lasting behavioral phenotypes (24 h post-treatment) via inducing different brain-derived neurotrophic factor (BDNF) expression level in the hippocampus

Wu, C., Wang, Y., Yang, H., Wu, S., Xie, Z., Zhang, J., He, L., Wang, Z., & He, L. (2019) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2019.107136 · Cited by 50

Resilience Dysregulation in Major Depressive Disorder: Focus on Glutamatergic Imbalance and Microglial Activation

Réus, G. Z., de Moura, A. B., da Silva, R. H., Resende, W. R., & Quevedo, J. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170630164715 · Cited by 51

Glutamatergic receptor and neuroplasticity in depression: Implications for ketamine and rapastinel as the rapid-acting antidepressants

Wang, Y., Zhang, N., Liu, L., Jiang, H., Hu, D., Wang, Z., Chen, N., & Zhang, Y. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.01.024 · Cited by 50

Activation of astrocytic sigma‐1 receptor exerts antidepressant‐like effect via facilitating CD38‐driven mitochondria transfer

Wang, Y., Ni, J., Gao, T., Gao, C., Guo, L., & Yin, X. (2020) · Glia · doi:10.1002/glia.23850 · Cited by 42

Ketamine: The final frontier or another depressing end?

Sial, O. K., Parise, E. M., Parise, L. F., Gnecco, T., & Bolaños‐Guzmán, C. A. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112508 · Cited by 41

Vesicular glutamate transporter 1 (VGLUT1)-mediated glutamate release and membrane GluA1 activation is involved in the rapid antidepressant-like effects of scopolamine in mice

Yu, H., Li, M., Zhou, D., Lv, D., Liao, Q., Lou, Z., Shen, M., Wang, Z., Li, M., Xiao, X., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.028 · Cited by 41

A single intravenous administration of a sub-anesthetic ketamine dose during the perioperative period of cesarean section for preventing postpartum depression: A meta-analysis.

Li, Q., Wang, S.-Y., & Mei, X. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114396 · Cited by 32

Neuroanatomical, Biochemical, and Functional Modifications in Brain Induced by Treatment with Antidepressants

Khushboo, Siddiqi, N. J., Pereira, M. D. L., & Sharma, B. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02780-z · Cited by 40

Diversity of AMPA Receptor Ligands: Chemotypes, Binding Modes, Mechanisms of Action, and Therapeutic Effects

Golubeva, E. A., Lavrov, M. I., Radchenko, E. V., & Palyulin, V. A. (2022) · Biomolecules · doi:10.3390/biom13010056 · Cited by 36

Advancements Exploring Major Depressive Disorder: Insights on Oxidative Stress, Serotonin Metabolism, BDNF, HPA Axis Dysfunction, and Pharmacotherapy Advances

Correia, A. S., & Vale, N. (2024) · International Journal of Translational Medicine · doi:10.3390/ijtm4010010 · Cited by 43

Ketamine can produce oscillatory dynamics by engaging mechanisms dependent on the kinetics of NMDA receptors

Adam, E. M., Kowalski, M., Akeju, O., Miller, E. K., Brown, E. N., McCarthy, M. M., & Kopell, N. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2402732121 · Cited by 37

Ketamine and Calcium Signaling—A Crosstalk for Neuronal Physiology and Pathology

Lisek, M., Żylińska, L., & Boczek, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218410 · Cited by 40

Neurocognitive Effects of Ketamine and Esketamine for Treatment-Resistant Major Depressive Disorder: A Systematic Review

Souza‐Marques, B., Santos‐Lima, C., Araújo-de-Freitas, L., Vieira, F., Jesus‐Nunes, A. P., Quarantini, L. C., & Sampaio, A. S. (2021) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000312 · Cited by 39

Acute treatment with ketamine and chronic treatment with minocycline exert antidepressant-like effects and antioxidant properties in rats subjected different stressful events

Maciel, A. L., Abelaira, H. M., de Moura, A. B., de Souza, T. G., Rosa, T., Matos, D., Tuon, T., Garbossa, L., Strassi, A. P., Fileti, M. E., et al. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.12.005 · Cited by 36

Recent insights into antidepressant therapy: Distinct pathways and potential common mechanisms in the treatment of depressive syndromes

van Calker, D., Serchov, T., Normann, C., & Biber, K. P. H. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.03.014 · Cited by 35

Is (R)-ketamine a potential therapeutic agent for treatment-resistant depression with less detrimental side effects? A review of molecular mechanisms underlying ketamine and its enantiomers

Scotton, E., Antqueviezc, B., Vasconcelos, M., Dalpiaz, G., Géa, L. P., Goularte, J. F., Colombo, R., & Rosa, A. R. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114963 · Cited by 37

Spontaneous respiratory plasticity following unilateral high cervical spinal cord injury in behaving rats

Bezdudnaya, T., Hormigo, K. M., Marchenko, V., & Lane, M. A. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.03.014 · Cited by 34

Maintenance Ketamine Therapy for Treatment-Resistant Depression

Archer, S., Chrenek, C., & Swainson, J. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000894 · Cited by 33

The ‘Yin’ and the ‘Yang’ of the kynurenine pathway: excitotoxicity and neuroprotection imbalance in stress-induced disorders

Barone, P. R. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000477 · Cited by 37

Multiple inducers and novel roles of autoantibodies against the obligatory NMDAR subunit NR1: a translational study from chronic life stress to brain injury

Pan, H., Steixner-Kumar, A. A., Seelbach, A., Deutsch, N. R., Ronnenberg, A., Tapken, D., von Ahsen, N., Mitjans, M., Worthmann, H., Trippe, R., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0672-1 · Cited by 35

Advances in novel molecular targets for antidepressants

Wang, Q., & Dwivedi, Y. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110041 · Cited by 33

The therapeutic role of ketamine and esketamine in treating psychopathological domains of depression

Jawad, M. Y., Vincenzo, J. D. D., Badulescu, S., Teopiz, K. M., Tabassum, A., Ceban, F., Mckenzie, A., Meshkat, S., Rosenblat, J. D., Ho, R., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109299 · Cited by 32

Effects of Ketamine on Rodent Fear Memory

Choi, K. H., Berman, R. Y., Zhang, M., Spencer, H. F., & Radford, K. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197173 · Cited by 31

Mechanisms of the Rapid Effects of Ketamine on Depression and Sleep Disturbances: A Narrative Review

Song, B., & Zhu, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.782457 · Cited by 31

Molecular Mechanisms of AMPA Receptor Trafficking in the Nervous System

Cao, Y., Ling-Ling, W., Li, X., Yuan, Y.-L., Zhao, W., Qi, J., Zhao, X.-Y., Ward, N., & Wang, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010111 · Cited by 34

A Novel Application of Ketamine for Improving Perioperative Sleep Disturbances

Song, B., & Zhu, J. (2021) · Nature and Science of Sleep · doi:10.2147/nss.s341161 · Cited by 30

Ketamine-Associated Intraoperative Electroencephalographic Signatures of Elderly Patients With and Without Preoperative Cognitive Impairment

Chang, O. L. B., Kreuzer, M., Morgen, D. F., Possin, K. L., & García, P. S. (2022) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005875 · Cited by 29

Ketamine as a therapeutic agent in major depressive disorder and posttraumatic stress disorder: Potential medicinal and deleterious effects

Sachdeva, B., Sachdeva, P., Ghosh, S., Ahmad, F., & Sinha, J. K. (2023) · Ibrain · doi:10.1002/ibra.12094 · Cited by 31

Storm on predictive brain: A neurocomputational account of ketamine antidepressant effect

Bottemanne, H., Berkovitch, L., Gauld, C., Balcerac, A., Schmidt, L., Mouchabac, S., & Fossati, P. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105410 · Cited by 30

AMPA receptor-mTORC1 signaling activation is required for neuroplastic effects of LY341495 in rat hippocampal neurons

Seo, M. K., Hiền, L. T. T., Park, M. K., Choi, A. J., Seog, D., Kim, S. H., Park, S. W., & Lee, J. G. (2020) · Scientific Reports · doi:10.1038/s41598-020-58017-3 · Cited by 24

The Glutamatergic System in Treatment-Resistant Depression and Comparative Effectiveness of Ketamine and Esketamine: Role of Inflammation?

Halaris, A. E., & Cook, J. T. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_21 · Cited by 27

Alterations in mGlu5 receptor expression and function in the striatum in a rat depression model

Mao, L., & Wang, J. Q. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14307 · Cited by 23

Interaction of Sex and Age on the Dissociative Effects of Ketamine Action in Young Healthy Participants

Derntl, B., Hornung, J., Şen, Z. D., Čolić, L., Li, M., & Walter, M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00616 · Cited by 23

Roles of non-receptor tyrosine kinases in pathogenesis and treatment of depression

Wang, J. Q., Derges, J. D., Bodepudi, A., Pokala, N., & Mao, L. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2101025 · Cited by 23

Reelin has antidepressant-like effects after repeated or singular peripheral injections

Allen, J., Romay-Tallón, R., Mitchell, M. A., Brymer, K. J., Johnston, J. N., Sánchez-Lafuente, C. L., Pinna, G., Kalynchuk, L. E., & Caruncho, H. J. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109043 · Cited by 22

Zelquistinel Is an Orally Bioavailable Novel NMDA Receptor Allosteric Modulator That Exhibits Rapid and Sustained Antidepressant-Like Effects

Burgdorf, J. S., Zhang, X., Stanton, P. K., Moskal, J. R., & Donello, J. E. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac043 · Cited by 23

Auxiliary subunits of AMPA receptors: The discovery of a forebrain-selective antagonist, LY3130481/CERC-611

Kato, A., & Witkin, J. M. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.09.015 · Cited by 22

Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects

Sartim, A. G., Marques, J., Silveira, K. M., Gobira, P. H., Guimarães, F. S., Wegener, G., & Joca, S. R. L. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108679 · Cited by 22

Hydroxynorketamine: Implications for the NMDA Receptor Hypothesis of Ketamine’s Antidepressant Action

Aleksandrova, L. R., Wang, Y. T., & Phillips, A. G. (2017) · Chronic Stress · doi:10.1177/2470547017743511 · Cited by 23

Tianeptine antagonizes the reduction of PV+ and GAD67 cells number in dorsal hippocampus of socially isolated rats

Perić, I., Stanisavljević, A., Inta, D., Gass, P., Lang, U. E., Borgwardt, S., & Filipović, D. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.10.013 · Cited by 19

AMPA receptors mediate the pro-cognitive effects of electrical and optogenetic stimulation of the medial prefrontal cortex in antidepressant non-responsive Wistar–Kyoto rats

Papp, M., Gruca, P., Łasoń, M., Litwa, E., Solecki, W., & Willner, P. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120967857 · Cited by 23

Strategies for Treatment-Resistant Depression: Lessons Learned from Animal Models

Réus, G. Z., de Moura, A. B., Borba, L. A., Abelaira, H. M., & Quevedo, J. (2019) · Complex Psychiatry · doi:10.1159/000500324 · Cited by 21

The neuroprotective effect and possible therapeutic application of xenon in neurological diseases

Zhang, M., Cui, Y., Cheng, Y., Wang, Q., & Sun, H. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24958 · Cited by 20

Indices of cortical plasticity after therapeutic sleep deprivation in patients with major depressive disorder

Kühn, M., Maier, J. G., Wolf, E., Mainberger, F., Feige, B., Maywald, S., Bredl, A., Michel, M., Sendelbach, N., Normann, C., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.08.052 · Cited by 20

Stress and Ketamine, Bimodal Influence on Cognitive Functions

Trofimiuk, E., Wielgat, P., Braszko, J. J., & Car, H. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.12.030 · Cited by 20

Sleep Disturbances and Depression Are Co-morbid Conditions: Insights From Animal Models, Especially Non-human Primate Model

Li, M., Cui, J., Xu, B., Wei, Y., Fu, C., Lv, X., Xiong, L., & Qin, D. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.827541 · Cited by 23

Effective Use of Animal Models for Therapeutic Development in Psychiatric and Substance Use Disorders

Phillips, A. G., Geyer, M. A., & Robbins, T. W. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.01.014 · Cited by 21

The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT2 receptors

Sayson, L. V., Botanas, C. J., Custodio, R. J. P., Abiero, A., Kim, M., Lee, H. J., Kim, H. J., Yoo, S. Y., Lee, K. W., Ryu, H. W., et al. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05219-x · Cited by 19

Vascular endothelial growth factor and pigment epithelial-derived factor in the peripheral response to ketamine

McGrory, C. L., Ryan, K. M., Gallagher, B., & McLoughlin, D. M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.04.013 · Cited by 19

Transcranial magnetic stimulation and ketamine: implications for combined treatment in depression

Dębowska, W., Więdłocha, M., Dębowska, M. D., Kownacka, Z., Marcinowicz, P., & Szulc, A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1267647 · Cited by 23

Effects of ketamine on orientation selectivity and variability of neuronal responses in primary visual cortex

Ouelhazi, A., Bharmauria, V., Chanauria, N., Bachatene, L., Lussiez, R., & Molotchnikoff, S. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146462 · Cited by 16

Treatment of cholinergic‐induced status epilepticus with polytherapy targeting GABA and glutamate receptors

Niquet, J., Nguyen, D. A., Furtado, M. D. A., & Lumley, L. A. (2023) · Epilepsia Open · doi:10.1002/epi4.12713 · Cited by 17

Genetic modulation of the HTR2A gene reduces anxiety-related behavior in mice

Rohn, T. T., Radin, D. I., Brandmeyer, T., Linder, B., Andriambeloson, E., Wagner, S., Kehler, J., Vasileva, A., Wang, H., Mee, J. L., et al. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgad170 · Cited by 19

Biodistribution and radiation dosimetry of the positron emission tomography probe for AMPA receptor, [11C]K-2, in healthy human subjects

Hatano, M., Miyazaki, T., Ishiwata, Y., Nakajima, W., Arisawa, T., Kuroki, Y., Kobayashi, A., Takada, Y., Ogawa, M., Kawamura, K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81002-3 · Cited by 18

Age affects temporal response, but not durability, to serial ketamine infusions for treatment refractory depression

Pennybaker, S. J., Roach, B. J., Fryer, S. L., Badathala, A., Wallace, A., Mathalon, D. H., & Marton, T. F. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05939-z · Cited by 17

The roles of neuroinflammation and glutamatergic excitotoxicity in treatment-resistant depression

Candee, R., Wilkenson, R., Schreiber, M., & Decenzo, M. (2023) · JAAPA : official journal of the American Academy of Physician Assistants · doi:10.1097/01.jaa.0000921252.57819.4b · Cited by 9

The role of mGluR5 on the therapeutic effects of ketamine in Wistar rats

Gokalp, D., & Ünal, G. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06571-3 · Cited by 16

Agmatine as a potential therapeutic intervention in bipolar depression: the preclinical landscape

Watts, D., Pfaffenseller, B., Wollenhaupt-Aguiar, B., Géa, L. P., Cardoso, T. D. A., & Kapczinski, F. P. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1581764 · Cited by 16

Gene expression signature of antidepressant treatment response/non-response in Flinders Sensitive Line rats subjected to maternal separation

Marchetti, L., Lauria, M., Caberlotto, L., Musazzi, L., Popoli, M., Mathé, A. A., Domenici, E., & Carboni, L. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.11.004 · Cited by 17

Antidepressant Actions of Ketamine: Potential Role of L-Type Calcium Channels

Robinson, B. L., Gu, Q., & Kanungo, J. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00411 · Cited by 16

Gender-Specific Effects of Two Treatment Strategies in a Mouse Model of Niemann-Pick Disease Type C1

Holzmann, C., Witt, M., Rolfs, A., Antipova, V., & Wree, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052539 · Cited by 16

Antidepressant effects of repeated s-ketamine administration as NMDAR Antagonist: Involvement of CaMKIIα and mTOR signaling in the hippocampus of CUMS mice

Liu, B., Du, Y., Xu, C. S., Liu, Q., & Zhang, L. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148375 · Cited by 18

Hippocampal Acetylation may Improve Prenatal-Stress-Induced Depression-Like Behavior of Male Offspring Rats Through Regulating AMPARs Expression

Lu, Y., Zhang, J., Zhang, L., Dang, S., Su, Q., Zhang, H., Lin, T., Zhang, X., Zhang, Y., Sun, H., et al. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2393-7 · Cited by 17

Ketamine alleviates fear memory and spatial cognition deficits in a PTSD rat model via the BDNF signaling pathway of the hippocampus and amygdala

Teng, Y., Niu, J., Liu, Y., Wang, H., Chen, J., Kong, Y., Wang, X., Lian, B., Wang, W., Sun, H., et al. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114792 · Cited by 17

Revealing brain mechanisms of mTOR-mediated translational regulation: Implications for chronic pain

Cho, C., Michailidis, V., & Martin, L. J. (2018) · Neurobiology of Pain · doi:10.1016/j.ynpai.2018.03.002 · Cited by 16

The NMDA receptor antagonists memantine and ketamine as anti-migraine agents

Podkowa, K., Czarnacki, K., Borończyk, A., Borończyk, M., & Paprocka, J. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02444-2 · Cited by 18

The rapid‐onset antidepressant effect of ketamine: More surprises?

Raffa, R. B., Pergolizzi, J. V., & Taylor, R. (2017) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12656 · Cited by 5

Mechanisms of ketamine action as an antidepressant

Zanos, P., & Gould, T. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.255 · Cited by 1,127

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

Morris, P. J., Yuan, P., Fang, Y., Mayo, C. L., Huang, X., Gould, T. D., Dossou, K. S. S., Moaddel, R., Wainer, I. W., Thomas, C. J., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/wfvq-kk18

Ketamine and other potential glutamate antidepressants

Dutta, A., McKie, S., & Deakin, J. F. W. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.10.028 · Cited by 92

Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors

Maeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103